{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:13:45Z","timestamp":1762431225696,"version":"3.37.3"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T00:00:00Z","timestamp":1481673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T00:00:00Z","timestamp":1481673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1111\/bjd.15174","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T16:40:03Z","timestamp":1481820003000},"page":"1021-1027","source":"Crossref","is-referenced-by-count":38,"title":["Acute skin and hair symptoms followed by severe, delayed eye complications in subjects using the synthetic opioid MT-45"],"prefix":"10.1093","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7480-8078","authenticated-orcid":false,"given":"A.","family":"Helander","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine; Karolinska Institutet; Stockholm Sweden"},{"name":"Departments of Clinical Chemistry and Clinical Pharmacology; Karolinska University Laboratory; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bradley","sequence":"additional","affiliation":[{"name":"Dermatology Unit; Department of Medicine Solna; Karolinska Institutet; Stockholm Sweden"},{"name":"Department of Dermatology; Karolinska University Hospital; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hasselblad","sequence":"additional","affiliation":[{"name":"Dermatology Unit; Department of Medicine Solna; Karolinska Institutet; Stockholm Sweden"},{"name":"Department of Dermatology; Karolinska University Hospital; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Norl\u00e9n","sequence":"additional","affiliation":[{"name":"Dermatology Unit; Department of Medicine Solna; Karolinska Institutet; Stockholm Sweden"},{"name":"Department of Dermatology; Karolinska University Hospital; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Vassilaki","sequence":"additional","affiliation":[{"name":"Dermatopathology Service; Dermipath AB; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"B\u00e4ckberg","sequence":"additional","affiliation":[{"name":"Swedish Poisons Information Centre; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lapins","sequence":"additional","affiliation":[{"name":"Dermatology Unit; Department of Medicine Solna; Karolinska Institutet; Stockholm Sweden"},{"name":"Department of Dermatology; Karolinska University Hospital; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,12,14]]},"reference":[{"key":"10.1111\/bjd.15174-BIB0001|bjd15174-cit-0001","first-page":"1417","article-title":"Nail abnormalities: clues to systemic disease","volume":"69","author":"Fawcett","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1111\/bjd.15174-BIB0002|bjd15174-cit-0002","unstructured":"EMCDDA EU Drug Markets Report 2016. In-depth Analysis 2016 http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/2373\/TD0216072ENN.PDF"},{"key":"10.1111\/bjd.15174-BIB0003|bjd15174-cit-0003","unstructured":"EMCDDA New Psychoactive Substances in Europe. An update from the EU Early Warning System (March 2015) 2015 http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_235958_EN_TD0415135ENN.pdf"},{"key":"10.1111\/bjd.15174-BIB0004|bjd15174-cit-0004","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/15563650.2015.1054505","article-title":"Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project","volume":"53","author":"B\u00e4ckberg","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1111\/bjd.15174-BIB0005|bjd15174-cit-0005","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/dta.274","article-title":"An analysis of legal highs: do they contain what it says on the tin?","volume":"3","author":"Baron","year":"2011","journal-title":"Drug Test Anal"},{"key":"10.1111\/bjd.15174-BIB0006|bjd15174-cit-0006","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/qjmed\/hcq056","article-title":"Purchasing \u2018legal highs\u2019 on the Internet - is there consistency in what you get?","volume":"103","author":"Davies","year":"2010","journal-title":"QJM"},{"key":"10.1111\/bjd.15174-BIB0007|bjd15174-cit-0007","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3109\/15563650.2014.920088","article-title":"Intoxications of the new psychoactive substance 5-(2-aminopropyl)indole (5-IT): a case series from the Swedish STRIDA project","volume":"52","author":"B\u00e4ckberg","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1111\/bjd.15174-BIB0008|bjd15174-cit-0008","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3109\/15563650.2014.981823","article-title":"Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project","volume":"53","author":"B\u00e4ckberg","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1111\/bjd.15174-BIB0009|bjd15174-cit-0009","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3109\/15563650.2015.1089576","article-title":"Intoxications involving MDPV in Sweden during 2010-2014: results from the STRIDA project","volume":"53","author":"Beck","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1111\/bjd.15174-BIB0010|bjd15174-cit-0010","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/15563650.2015.1033630","article-title":"Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine","volume":"53","author":"Helander","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1111\/bjd.15174-BIB0011|bjd15174-cit-0011","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3109\/15563650.2014.943908","article-title":"MT-45, a new psychoactive substance associated with hearing loss and unconsciousness","volume":"52","author":"Helander","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1111\/bjd.15174-BIB0012|bjd15174-cit-0012","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jat\/bku057","article-title":"Fatal intoxications associated with the designer opioid AH-7921","volume":"38","author":"Kronstrand","year":"2014","journal-title":"J Anal Toxicol"},{"key":"10.1111\/bjd.15174-BIB0013|bjd15174-cit-0013","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s13181-011-0196-9","article-title":"Death following recreational use of designer drug \u2018bath salts\u2019 containing 3,4-Methylenedioxypyrovalerone (MDPV)","volume":"8","author":"Murray","year":"2012","journal-title":"J Med Toxicol"},{"key":"10.1111\/bjd.15174-BIB0014|bjd15174-cit-0014","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.forsciint.2014.02.022","article-title":"Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project","volume":"243","author":"Helander","year":"2014","journal-title":"Forensic Sci Int"},{"key":"10.1111\/bjd.15174-BIB0015|bjd15174-cit-0015","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/00365513.2013.793817","article-title":"Identification of novel psychoactive drug use in Sweden based on laboratory analysis - initial experiences from the STRIDA project","volume":"73","author":"Helander","year":"2013","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/bjd.15174-BIB0016|bjd15174-cit-0016","unstructured":"Erowid.org. Synthesis of phenyl-2-propanone (P2P) https:\/\/www.erowid.org\/archive\/rhodium\/chemistry\/phenylacetone.html"},{"key":"10.1111\/bjd.15174-BIB0017|bjd15174-cit-0017","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40199-015-0121-x","article-title":"Thallium exists in opioid poisoned patients","volume":"23","author":"Ghaderi","year":"2015","journal-title":"Daru"},{"key":"10.1111\/bjd.15174-BIB0018|bjd15174-cit-0018","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1021\/jm00246a014","article-title":"Studies on 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives and their analgesic activities. 1","volume":"18","author":"Natsuka","year":"1975","journal-title":"J Med Chem"},{"key":"10.1111\/bjd.15174-BIB0019|bjd15174-cit-0019","unstructured":"EMCDDA EMCDDA-Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (\u2018MT-45\u2019) 2014 http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_230615_EN_TDAS14007ENN.pdf"},{"key":"10.1111\/bjd.15174-BIB0020|bjd15174-cit-0020","unstructured":"EMCDDA Report on the Risk Assessment of MT-45 in the Framework of the Council Decision on New Psychoactive Substances 2015 http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/1865\/TDAK14006ENN.pdf"},{"key":"10.1111\/bjd.15174-BIB0021|bjd15174-cit-0021","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jat\/bkw012","article-title":"Analysis of MT-45, a novel synthetic opioid, in human whole blood by LC-MS-MS and its identification in a drug-related death","volume":"40","author":"Papsun","year":"2016","journal-title":"J Anal Toxicol"},{"key":"10.1111\/bjd.15174-BIB0022|bjd15174-cit-0022","first-page":"1712","article-title":"MT-45 - a dangerous and potentially ototoxic Internet drug [in Swedish]","volume":"111","author":"Lindeman","year":"2014","journal-title":"L\u00e4kartidningen"},{"key":"10.1111\/bjd.15174-BIB0023|bjd15174-cit-0023","unstructured":"Bluelight.org. Longer Term Negative Side Effects of MT45 Use. IMPORTANT http:\/\/www.bluelight.org\/vb\/threads\/749518-Longer-term-negative-side-effects-of-MT45-use-IMPORTANT"},{"key":"10.1111\/bjd.15174-BIB0024|bjd15174-cit-0024","first-page":"217","article-title":"Cutaneous side effects from use of triparanol (MER-29): preliminary data on ichthyosis and loss of hair","volume":"36","author":"Achor","year":"1961","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1111\/bjd.15174-BIB0025|bjd15174-cit-0025","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/archderm.1963.01590150088016","article-title":"Cutaneous syndromes produced as side effects of triparanol therapy","volume":"87","author":"Winkelmann","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.15174-BIB0026|bjd15174-cit-0026","first-page":"494","article-title":"Cataracts produced by triparanol (MER-29)","volume":"65","author":"Kirby","year":"1967","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1111\/bjd.15174-BIB0027|bjd15174-cit-0027","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2307\/3479500","article-title":"The MER\/29 Story - an instance of successful mass disaster litigation","volume":"56","author":"Rheingold","year":"1968","journal-title":"Cal L Rev"},{"key":"10.1111\/bjd.15174-BIB0028|bjd15174-cit-0028","first-page":"597","article-title":"Complications in the use of triparanol (MER-29). Report of a case of ichthyosis, loss of hair, and change in hair color","volume":"45","author":"Perry","year":"1962","journal-title":"Minn Med"},{"key":"10.1111\/bjd.15174-BIB0029|bjd15174-cit-0029","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/BF02341263","article-title":"The clinical evaluation of a new butyrophenone (WY-3457)","volume":"5","author":"Simpson","year":"1964","journal-title":"Psychopharmacologia"},{"key":"10.1111\/bjd.15174-BIB0030|bjd15174-cit-0030","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/019262301317052440","article-title":"Toxicologic lesions associated with two related inhibitors of oxidosqualene cyclase in the dog and mouse","volume":"29","author":"Pyrah","year":"2001","journal-title":"Toxicol Pathol"},{"key":"10.1111\/bjd.15174-BIB0031|bjd15174-cit-0031","volume-title":"Human Embryology and Developmental Biology","author":"Carlson","year":"2014","edition":"5"},{"key":"10.1111\/bjd.15174-BIB0032|bjd15174-cit-0032","first-page":"DTAF","article-title":"Akut kutant symptom komplex med efterf\u00f6ljande katarakt - N\u00e4tdrogen MT-45 kan vara orsaken [in Swedish]","volume":"113","author":"Bradley","year":"2016","journal-title":"L\u00e4kartidningen"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15174","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15174","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.15174\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:24:28Z","timestamp":1676384668000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/176\/4\/1021\/6748056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,14]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.15174","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"type":"print","value":"0007-0963"}],"subject":[],"published":{"date-parts":[[2016,12,14]]}}}